Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2013

01-06-2013 | Original Research

Nutrients from Fruit and Vegetable Consumption Reduce the Risk of Pancreatic Cancer

Authors: Rick J. Jansen, Dennis P. Robinson, Rachael Z. Stolzenberg-Solomon, William R. Bamlet, Mariza de Andrade, Ann L. Oberg, Kari G. Rabe, Kristin E. Anderson, Janet E. Olson, Rashmi Sinha, Gloria M. Petersen

Published in: Journal of Gastrointestinal Cancer | Issue 2/2013

Login to get access

Abstract

Purpose

Pancreatic cancer is a devastating disease for which the role of dietary factors remains inconclusive. Our objective was to evaluate the risk of pancreatic cancer associated with nutrients found in fruits and vegetables and nutrient supplementation using a clinic-based case–control design.

Methods

Our study included 384 rapidly ascertained cases and 983 controls frequency-matched on age at time of recruitment (in 5-year increments), race, sex, and region of residence. All subjects provided demographic information and completed a 144-item food frequency questionnaire in which they reported no change to their diet within 5 years prior to entering the study. Logistic regression was used to calculate odds ratios and 95 % confidence intervals, adjusted for age, sex, smoking, body mass index, energy intake, and alcohol consumption.

Results

Results show a significant (trend p value < 0.05) inverse association between pancreatic cancer and nutrient/supplement groupings in a dose-dependent manner including magnesium, potassium, selenium, alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein and zeaxanthin, niacin, total alpha-tocopherol, total vitamin A activity, vitamin B6, and vitamin C. Adjusting for diabetes or total sugar intake did not result in significant changes.

Conclusion

We conclude that most nutrients obtained through consumption of fruits and vegetables may reduce the risk of developing pancreatic cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. Accessed 18 Nov 2011. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://​globocan.​iarc.​fr. Accessed 18 Nov 2011.
2.
go back to reference American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012. Accessed 3 Mar 2012. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012. Accessed 3 Mar 2012.
3.
go back to reference Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284–94.CrossRefPubMed Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284–94.CrossRefPubMed
4.
go back to reference Klapman J, Malafa MP. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control. 2008;15:280–7.PubMed Klapman J, Malafa MP. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control. 2008;15:280–7.PubMed
5.
go back to reference Howe GR, Ghadirian P, Bueno de Mesquita HB, Zatonski WA, Baghurst PA, Miller AB, Simard A, Baillargeon J, de Waard F, Przewozniak K, et al. A collaborative case–control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer. 1992;51:365–72.CrossRefPubMed Howe GR, Ghadirian P, Bueno de Mesquita HB, Zatonski WA, Baghurst PA, Miller AB, Simard A, Baillargeon J, de Waard F, Przewozniak K, et al. A collaborative case–control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer. 1992;51:365–72.CrossRefPubMed
6.
go back to reference Nkondjock A, Ghadirian P, Johnson KC, Krewski D. Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr. 2005;135:592–7.PubMed Nkondjock A, Ghadirian P, Johnson KC, Krewski D. Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr. 2005;135:592–7.PubMed
7.
go back to reference Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case–control study. Cancer Causes Control. 1991;2:291–7.CrossRefPubMed Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case–control study. Cancer Causes Control. 1991;2:291–7.CrossRefPubMed
8.
go back to reference Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991;47:1–6.CrossRefPubMed Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991;47:1–6.CrossRefPubMed
9.
go back to reference Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst. 1999;91:535–41.CrossRefPubMed Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst. 1999;91:535–41.CrossRefPubMed
10.
go back to reference Foksinski M, Gackowski D, Rozalski R, Siomek A, Guz J, Szpila A, Dziaman T, Olinski R. Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr. 2007;46:174–80.CrossRefPubMed Foksinski M, Gackowski D, Rozalski R, Siomek A, Guz J, Szpila A, Dziaman T, Olinski R. Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr. 2007;46:174–80.CrossRefPubMed
11.
go back to reference Morales E, Porta M, Vioque J, Lopez T, Mendez MA, Pumarega J, Malats N, Crous-Bou M, Ngo J, Rifa J, Carrato A, Guarner L, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health. 2007;61:641–9.CrossRefPubMed Morales E, Porta M, Vioque J, Lopez T, Mendez MA, Pumarega J, Malats N, Crous-Bou M, Ngo J, Rifa J, Carrato A, Guarner L, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health. 2007;61:641–9.CrossRefPubMed
12.
go back to reference Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y. Nutritional factors and risk of pancreatic cancer: a population-based case–control study based on direct interview in Japan. J Gastroenterol. 2005;40:297–301.CrossRefPubMed Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y. Nutritional factors and risk of pancreatic cancer: a population-based case–control study based on direct interview in Japan. J Gastroenterol. 2005;40:297–301.CrossRefPubMed
13.
go back to reference Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002;155:783–92.CrossRefPubMed Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol. 2002;155:783–92.CrossRefPubMed
14.
go back to reference Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20:825–34.CrossRefPubMed Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control. 2009;20:825–34.CrossRefPubMed
15.
go back to reference Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni Jr JF, et al. Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710–9.CrossRefPubMed Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni Jr JF, et al. Dietary and nutritional factors and pancreatic cancer: a case–control study based on direct interviews. J Natl Cancer Inst. 1998;90:1710–9.CrossRefPubMed
16.
go back to reference Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R, Petersen GM. Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control. 2011;22:1613–25.CrossRefPubMed Jansen RJ, Robinson DP, Stolzenberg-Solomon RZ, Bamlet WR, de Andrade M, Oberg AL, Hammer TJ, Rabe KG, Anderson KE, Olson JE, Sinha R, Petersen GM. Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control. 2011;22:1613–25.CrossRefPubMed
17.
go back to reference Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1455–9.CrossRefPubMed Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1455–9.CrossRefPubMed
19.
go back to reference Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17–27.PubMed Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17–27.PubMed
20.
go back to reference SAS® software Version 9.2 of the SAS System for Unix ed. Version 9.2 Cary, NC, USA: Copyright © 9.2 SAS Institute Inc.:SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA. SAS® software Version 9.2 of the SAS System for Unix ed. Version 9.2 Cary, NC, USA: Copyright © 9.2 SAS Institute Inc.:SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
21.
go back to reference Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561–7.CrossRefPubMed Stattin P, Bjor O, Ferrari P, Lukanova A, Lenner P, Lindahl B, Hallmans G, Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care. 2007;30:561–7.CrossRefPubMed
22.
go back to reference Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552–8.CrossRefPubMed Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA. 2000;283:2552–8.CrossRefPubMed
23.
go back to reference Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA. 2005;294:2872–8.CrossRefPubMed Stolzenberg-Solomon RZ, Graubard BI, Chari S, Limburg P, Taylor PR, Virtamo J, Albanes D. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA. 2005;294:2872–8.CrossRefPubMed
24.
go back to reference McCarty MF. Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses. 2001;57:146–50.CrossRefPubMed McCarty MF. Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses. 2001;57:146–50.CrossRefPubMed
25.
go back to reference Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:2101–9.CrossRefPubMed Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:2101–9.CrossRefPubMed
26.
go back to reference Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996;63:310–3.CrossRefPubMed Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996;63:310–3.CrossRefPubMed
27.
go back to reference Kazakoff K, Cardesa T, Liu J, Adrian TE, Bagchi D, Bagchi M, Birt DF, Pour PM. Effects of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer. 1996;26:265–79.CrossRefPubMed Kazakoff K, Cardesa T, Liu J, Adrian TE, Bagchi D, Bagchi M, Birt DF, Pour PM. Effects of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer. 1996;26:265–79.CrossRefPubMed
28.
go back to reference Zagorsky JL. Health and wealth. The late-20th century obesity epidemic in the U.S. Econ Hum Biol. 2005;3:296–313.CrossRefPubMed Zagorsky JL. Health and wealth. The late-20th century obesity epidemic in the U.S. Econ Hum Biol. 2005;3:296–313.CrossRefPubMed
29.
go back to reference Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. Horm Metab Res. 2003;35:694-704. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. Horm Metab Res. 2003;35:694-704.
30.
go back to reference Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134–40.CrossRefPubMed Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, Hu FB. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134–40.CrossRefPubMed
31.
go back to reference Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord. 2002;26:469–74.CrossRefPubMed Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord. 2002;26:469–74.CrossRefPubMed
32.
go back to reference Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol. 1995;269:E745–52.PubMed Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol. 1995;269:E745–52.PubMed
33.
go back to reference Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007;85:1068–74.PubMed Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007;85:1068–74.PubMed
34.
go back to reference Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78:1510–4.CrossRefPubMed Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78:1510–4.CrossRefPubMed
35.
go back to reference Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147–52.CrossRefPubMed Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147–52.CrossRefPubMed
36.
go back to reference Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208–14.CrossRefPubMed Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208–14.CrossRefPubMed
37.
go back to reference Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case–control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005;14:2093–7.CrossRefPubMed Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case–control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005;14:2093–7.CrossRefPubMed
38.
go back to reference Stolzenberg-Solomon RZ, Sheffler-Collins S, Weinstein S, Garabrant DH, Mannisto S, Taylor P, Virtamo J, Albanes D. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am J Clin Nutr. 2009;89:584–91.CrossRefPubMed Stolzenberg-Solomon RZ, Sheffler-Collins S, Weinstein S, Garabrant DH, Mannisto S, Taylor P, Virtamo J, Albanes D. Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am J Clin Nutr. 2009;89:584–91.CrossRefPubMed
39.
go back to reference Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1251–4. Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:1251–4.
40.
go back to reference Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112:1037–42.CrossRefPubMed Wheatley-Price P, Asomaning K, Reid A, Zhai R, Su L, Zhou W, Zhu A, Ryan DP, Christiani DC, Liu G. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer. 2008;112:1037–42.CrossRefPubMed
41.
go back to reference Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50:85–94.CrossRefPubMed Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50:85–94.CrossRefPubMed
42.
43.
go back to reference Dauchet L, Peneau S, Bertrais S, Vergnaud AC, Estaquio C, Kesse-Guyot E, Czernichow S, Favier A, Faure H, Galan P, Hercberg S. Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. Br J Nutr. 2008;100:633–41.CrossRefPubMed Dauchet L, Peneau S, Bertrais S, Vergnaud AC, Estaquio C, Kesse-Guyot E, Czernichow S, Favier A, Faure H, Galan P, Hercberg S. Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. Br J Nutr. 2008;100:633–41.CrossRefPubMed
44.
go back to reference Nkondjock A, Krewski D, Johnson KC, Ghadirian P. Dietary patterns and risk of pancreatic cancer. Int J Cancer. 2005;114:817–23.CrossRefPubMed Nkondjock A, Krewski D, Johnson KC, Ghadirian P. Dietary patterns and risk of pancreatic cancer. Int J Cancer. 2005;114:817–23.CrossRefPubMed
45.
go back to reference Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested case–control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol. 2003;32:257–62.CrossRefPubMed Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested case–control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol. 2003;32:257–62.CrossRefPubMed
46.
go back to reference Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.CrossRefPubMed Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.CrossRefPubMed
47.
go back to reference Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003;26:23–7.CrossRefPubMed Cullen JJ, Mitros FA, Oberley LW. Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas. 2003;26:23–7.CrossRefPubMed
48.
go back to reference Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res. 2004;38:1223–33.CrossRefPubMed Ough M, Lewis A, Zhang Y, Hinkhouse MM, Ritchie JM, Oberley LW, Cullen JJ. Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res. 2004;38:1223–33.CrossRefPubMed
Metadata
Title
Nutrients from Fruit and Vegetable Consumption Reduce the Risk of Pancreatic Cancer
Authors
Rick J. Jansen
Dennis P. Robinson
Rachael Z. Stolzenberg-Solomon
William R. Bamlet
Mariza de Andrade
Ann L. Oberg
Kari G. Rabe
Kristin E. Anderson
Janet E. Olson
Rashmi Sinha
Gloria M. Petersen
Publication date
01-06-2013
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2013
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-012-9441-y

Other articles of this Issue 2/2013

Journal of Gastrointestinal Cancer 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.